相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer
Jiang Chen et al.
BMC GASTROENTEROLOGY (2021)
Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection
Li-Peng Zhang et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
Haoda Chen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
Kabsoo Shin et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
Erkan Topkan et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
Barbara Wlodarczyk et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2021)
Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival
Ulrike Heger et al.
HPB (2020)
Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma
Barbara Wlodarczyk et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)
Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
Tessa Y. S. Le Large et al.
ONCOLOGIST (2020)
CA19-9 for detecting recurrence of pancreatic cancer
Azadeh Azizian et al.
SCIENTIFIC REPORTS (2020)
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
Huan Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
David N. Brindley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients
Shuichi Aoki et al.
BMC CANCER (2019)
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression
Francesca R. Auciello et al.
CANCER DISCOVERY (2019)
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
Rahat Jahan et al.
EBIOMEDICINE (2019)
Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
Tetsushi Hirahara et al.
BMC CANCER (2019)
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
Elena Campello et al.
BRITISH JOURNAL OF CANCER (2019)
Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer
Jin Song et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer
Ke Zhang et al.
PANCREATOLOGY (2019)
Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma
Fuyuhiko Motoi et al.
WORLD JOURNAL OF SURGERY (2019)
Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study
Jaime de la Fuente et al.
PANCREATOLOGY (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC)
Justyna Zinczuk et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
Katarzyna Winter et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2019)
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Sunghwan Suh et al.
DIABETES & METABOLISM JOURNAL (2019)
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time
Caroline J. Rieser et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients
Yongping Zhou et al.
CLINICA CHIMICA ACTA (2018)
The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC)
Barbara Wlodarczyk et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
John B. Allard et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Prognostic Significance of Albumin-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer
Xiang Li et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer
Lumir Kunovsky et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Mutlu Dogan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells
Kaori Fukushima et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2018)
Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy
Hiroyuki Asama et al.
MOLECULAR AND CLINICAL ONCOLOGY (2018)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
Jungsun Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
Jiyoung Park et al.
ONCOTARGET (2017)
Prognostic value of MICA/B in cancers: a systematic review and meta-analysis
Yijing Zhao et al.
ONCOTARGET (2017)
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
Xiaohui Liu et al.
BRITISH JOURNAL OF CANCER (2017)
Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis
Jana Rychlikova et al.
CANCER BIOMARKERS (2016)
IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma
Song Gao et al.
CANCER RESEARCH (2016)
Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer
Tadafumi Asaoka et al.
PANCREATOLOGY (2016)
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
Toshihiro Yoneyama et al.
PLOS ONE (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
New insights into the autotaxin/LPA axis in cancer development and metastasis
Raphael Leblanc et al.
EXPERIMENTAL CELL RESEARCH (2015)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer
Florian Gebauer et al.
PLOS ONE (2014)
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
Peng Xue et al.
CANCER MEDICINE (2014)
Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System
Barry J. Laird et al.
CLINICAL CANCER RESEARCH (2013)
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
Xiaomeng Wang et al.
NATURE (2013)
Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
Umashankar K. Ballehaninna et al.
TUMOR BIOLOGY (2013)
An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression
Jungsun Kim et al.
CELL REPORTS (2013)
Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
Shojiro Hata et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer
Ludmila Katherine Martin et al.
MEDICAL ONCOLOGY (2012)
The EMT regulator slug and lung carcinogenesis
Jin-Yuan Shih et al.
CARCINOGENESIS (2011)
Specific increase in serum autotaxin activity in patients with pancreatic cancer
Yousuke Nakai et al.
CLINICAL BIOCHEMISTRY (2011)
Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets
Shunli Lv et al.
DIAGNOSTIC CYTOPATHOLOGY (2011)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
D-dimer antigen: current concepts and future prospects
Soheir S. Adam et al.
BLOOD (2009)
Are trefoil factors oncogenic?
Jo K. Perry et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
CEACAM1, a novel serum biomarker for pancreatic cancer
Diane M. Simeone et al.
PANCREAS (2007)
Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: Lessons from multiple sclerosis
R. A. Adams et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Serum markers in patients with resectable pancreatic adenocarcinoma: Macrophage inhibitory cytokine 1 versus CA19-9
J Koopmann et al.
CLINICAL CANCER RESEARCH (2006)
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Jamael El Fitori et al.
CANCER CELL INTERNATIONAL (2005)
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
JE Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
分享论文
